| CRISPR Medicine | This is an overview of all our articles
Researchers have used a two-guide CRISPR knock-in technique to replace the entire coding sequence (CDS) of the synaptic LRRTM2 protein (Leucine-Rich...
CRISPRMED25 is an event not to be missed, but don't take it from us! Hear what some of CRISPRMED24 attendees have to say about the conference in this...
Members of the GenE-HumDi COST Action Working Group have examined the diverse systems developed for the delivery of CRISPR genome-editing tools. The...
Some of the best links we picked up around the internet
2024 was a fantastic year for the CRISPR Medicine community. In this piece, we look back on some highlights from the year.
Researchers in China report that targeting mutant HTT RNA with CRISPR/CasRx reduces the expression of diseased huntingtin protein and improves...
Tune Therapeutics has announced regulatory approval to begin a Phase 1b trial of its chronic hepatitis B therapy in Hong Kong, marking a strategic...
